Vaccine-induced immune response to omicron wanes substantially over time
Although COVID-19 booster vaccinations in adults elicit high levels of neutralizing antibodies against the Omicron variant of SARS-CoV-2, antibody levels decrease substantially within 3 months, according to new clinical trial data. The findings, published today in Cell Reports Medicine, are from a study sponsored by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health. The trial was led by NIAID's Infectious Diseases Clinical Research Consortium.
Source: World Pharma News - Category: Pharmaceuticals Tags: Featured Research Research and Development Source Type: news
More News: Allergy | Allergy & Immunology | Clinical Trials | Covid Vaccine | COVID-19 | Infectious Diseases | National Institutes of Health (NIH) | Pharmaceuticals | SARS | Study | Vaccines